Heterologous production, purification and crystallization of 24C-sterol methyltransferase fromCandida albicans
Mpontshane NS. et al, (2025)
Toward target 2035: EUbOPEN - a public-private partnership to enable & unlock biology in the open.
Tredup C. et al, (2024), RSC Med Chem
Critical assessment of LC3/GABARAP ligands used for degrader development and ligandability of LC3/GABARAP binding pockets.
Schwalm MP. et al, (2024), Nat Commun, 15
High-throughput crystallographic fragment screening of Zika virus NS3 Helicase.
Godoy AS. et al, (2024)
A selection of Golden Gate vectors to simplify recombinant protein production inEscherichia coli
Fairhead M. et al, (2024)
Accelerating Drug Discovery With High-Throughput Crystallographic Fragment Screening and Structural Enablement
Fearon D. et al, (2024), Applied Research
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
Boby ML. et al, (2023), Science, 382
Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity Search.
Wills S. et al, (2023), J Chem Inf Model, 63, 3423 - 3437
Allosteric regulation and crystallographic fragment screening of SARS-CoV-2 NSP15 endoribonuclease.
Godoy AS. et al, (2023), Nucleic Acids Res, 51, 5255 - 5270
A Small Step Toward Generalizability: Training a Machine Learning Scoring Function for Structure-Based Virtual Screening.
Scantlebury J. et al, (2023), J Chem Inf Model, 63, 2960 - 2974
Turning high-throughput structural biology into predictive inhibitor design.
Saar KL. et al, (2023), Proc Natl Acad Sci U S A, 120
Room-temperature crystallography reveals altered binding of small-molecule fragments to PTP1B.
Skaist Mehlman T. et al, (2023), Elife, 12
Discovery and Development Strategies for SARS-CoV-2 NSP3 Macrodomain Inhibitors.
Schuller M. et al, (2023), Pathogens, 12